X

LATEST

Ocean Biomedical presents novel malaria therapeutic discoveries at NIH Laboratory of Malaria Vaccinology and Immunology

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

Next.e.GO Mobile has a unique, innovative production strategy: Chairman Ali Vezvaei

Next.e.GO Mobile SE is a manufacturer of electric vehicles for urban mobility, with a mission to provide convenient and cost-effective…

Lightwave Logic will license technology to make its polymers ubiquitous: CEO Dr. Michael Lebby

The widespread digital transformation and steady increase in online content consumption have accentuated the demand for better data transmission solutions.…

Ocean Biomedical co-founder Jake Kurtis gets new patent for novel malaria vaccine target

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jonathan Kurtis received a new patent for his…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

The global pharmaceutical market is expected to cross $1.5 trillion this year, which represents a 4-5% annual growth over the…

Current initiatives should enable Flux Power to reach profitability: CEO Ron Dutt

Flux Power Holdings, Inc. (NASDAQ: FLUX) is a leading provider of lithium-ion energy storage electrification solutions for industrial and commercial…

Modulex Modular Buildings plans 20 factories in 15 countries: CEO Suchit Punnose

Modulex Modular Buildings Plc. is a construction company with a difference -- it is specialized in the development of environment-friendly…

Progress Software Corp (PRGS) Q4 2022 Earnings Call Transcript

Progress Software Corp (NASDAQ:PRGS) Q4 2022 Earnings Call dated Jan. 17, 2023. Corporate Participants: Michael Micciche -- Vice President, Investor Relations Yogesh…

Solar Integrated Roofing is on track to list on Nasdaq in 2023: CEO George Holmes

The steady growth of the renewable energy sector has accelerated the country’s clean energy revolution in recent years. Of late,…

Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary

Trxade Health Inc. (NASDAQ: MEDS), an integrated drug procurement and delivery platform, is on a mission to empower the independent…